JFA
GNOM icon

JNBA Financial Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

JNBA Financial Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-63
Closed -$6K – 838
2021
Q3 		$6K Hold
63
– – ﹤0.01% 569
2021
Q2 		$6K Hold
63
– – ﹤0.01% 533
2021
Q1 		$6K Hold
63
– – ﹤0.01% 512
2020
Q4 		$6K Buy
+63
New +$5.27K ﹤0.01% 483

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

JNBA Financial Advisors's GNOM Position: Q4 2021 in Review

JNBA Financial Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2021, closing a stake of 63 shares — an estimated $6K sold.

JNBA Financial Advisors first reported a position in GNOM in Q4 2020 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2021.

  • JNBA Financial Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • JNBA Financial Advisors sold 63 Global X Genomics & Biotechnology ETF shares in Q4 2021, an estimated $6K.
  • JNBA Financial Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and held it in 4 quarters.
  • JNBA Financial Advisors's Global X Genomics & Biotechnology ETF position peaked at $6K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2021.

Based on JNBA Financial Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.